Back to top
more

Innovus Pharmaceuticals, Inc. (INNV)

(Delayed Data from OTC)

$1.68 USD

1.68
6,037

-0.07 (-4.00%)

Updated Nov 12, 2019 11:33 AM ET

Add to portfolio

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.51%
17.57%
9.27%
4.95%
1.80%
10.51%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

NA Value | NA Growth | NA Momentum | NA VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Brokerage Reports

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

0 items in cart

PROVIDER: H.C. Wainwright & Co., Inc.

Reports for Purchase

Showing records 141 - 160 ( 9911 total )

Company: Tetraphase Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 141

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: CareDx, Inc.

Industry: Medical Services

Record: 142

11/05/2019

Company Report

Pages: 5

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: XOMA Corporation

Industry: Medical - Biomedical and Genetics

Record: 143

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Coherus BioSciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 144

11/05/2019

Daily Note

Pages: 4

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Pieris Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 145

11/05/2019

Daily Note

Pages: 4

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Edge Therapeutics, Inc.

Industry: Medical - Biomedical and Genetics

Record: 146

11/05/2019

Company Report

Pages: 30

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 75.00

Available: 12/05/2019

Research Provided by a Third Party

Company: aTyr Pharma, Inc.

Industry: Medical - Biomedical and Genetics

Record: 147

11/05/2019

Company Report

Pages: 33

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 75.00

Available: 12/05/2019

Research Provided by a Third Party

Company: AVEO Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 148

11/05/2019

Daily Note

Pages: 3

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Evolus, Inc.

Industry: Medical - Products

Record: 149

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Energy Fuels Inc

Industry: Mining - Non Ferrous

Record: 150

11/05/2019

Company Report

Pages: 5

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: IHLE H

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Lion Biotechnologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 151

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Trevena, Inc.

Industry: Medical - Biomedical and Genetics

Record: 152

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Karyopharm Therapeutics Inc.

Industry: Medical - Drugs

Record: 153

11/05/2019

Company Report

Pages: 8

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Minerva Neurosciences, Inc

Industry: Medical - Drugs

Record: 154

11/05/2019

Company Report

Pages: 6

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: ChemoCentryx, Inc.

Industry: Medical - Drugs

Record: 155

11/05/2019

Company Report

Pages: 8

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Tyme Technologies, Inc.

Industry: Medical - Drugs

Record: 156

11/05/2019

Company Report

Pages: 7

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: DURECT Corporation

Industry: Medical - Drugs

Record: 157

11/05/2019

Company Report

Pages: 8

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Turning Point Therapeutics, Inc.

Industry: Medical - Drugs

Record: 158

11/05/2019

Company Report

Pages: 5

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: EYEPOINT PHARMACEUTICALS, INC.

Industry: Medical - Biomedical and Genetics

Record: 159

11/05/2019

Company Report

Pages: 5

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 10.00

Available: 12/05/2019

Research Provided by a Third Party

Company: Viking Therapeutics, Inc.

Industry: Medical - Biomedical and Genetics

Record: 160

11/05/2019

Company Report

Pages: 7

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Available: 12/05/2019

Research Provided by a Third Party